5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer’s disease
Open Access
- 31 December 2006
- journal article
- Published by Elsevier BV in Medical Hypotheses
- Vol. 66 (3), 501-503
- https://doi.org/10.1016/j.mehy.2005.09.031
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic strokeAnnals of Neurology, 2005
- Aggregation of vascular risk factors and risk of incident Alzheimer diseaseNeurology, 2005
- APOE , vascular pathology, and the AD brainNeurology, 2005
- Association between the Gene Encoding 5-Lipoxygenase–Activating Protein and Stroke Replicated in a Scottish PopulationAmerican Journal of Human Genetics, 2005
- P3-284 5-Lipoxygenase protein is elevated in the hippocampus of Alzheimer's disease patientsNeurobiology of Aging, 2004
- The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and strokeNature Genetics, 2004
- Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and AtherosclerosisThe New England Journal of Medicine, 2004
- Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in MiceCirculation Research, 2002
- 5-Lipoxygenase (5-LOX) Promoter Polymorphism in Patients With Early-Onset and Late-Onset Alzheimer's DiseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 2001
- 5-Lipoxygenase gene polymorphism and onset of Alzheimer's diseaseMedical Hypotheses, 2000